Author name: k2_adm

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million investment allocation via the Startup SG Equity scheme.

Having invested in more than 15 companies, Ozi Amanat’s K2 VC is one of Singapore’s largest firms which was recently backed by the Singapore Government to invest upto $100 million fund in promising businesses in the region.

For Ozi Amanat, meritocracy and infinite possibilities were the draws to venture capital. “When a chance came to endeavour a life in venture capitalism, it wasn’t one road or the other but a culmination of experience of a thousand hours in the ecosystem,” says the psychology and economics graduate from Harvard. Finding promising startups that

Inside a society where face value and making impressions are everything, authenticity has become an almost rare commodity. But for venture capitalist Ozi Amanat, there is nothing more important than relationships – especially in the realm of deal-making.

Pod Foods is keeping grocery shelves full of the emerging food brands that consumers are asking for and announced today $13 million in funding, including $10 million in Series A dollars and $3 million in a previously unannounced seed round, to continue developing its digital wholesale business-to-business marketplace.

Singapore-based personalised wellness startup Imagene Labs has raised an undisclosed amount of funding in a Series A+ round led by Formation 8. The round was joined by K2 Global, Singaporean billionaire Ron Sim via R3 Asset Management, Raffles Venture Partners, Enterprise Singapore Seed Capital and prominent Singaporean angel investor

SINGAPORE, Jan. 20, 2020 /PRNewswire/ — TurtleTree Labs, the Singapore-based company working with biotechnology to create the full nutritional content of milk, today announced today that it has completed its pre-seed funding round.

TurtleTree Labs is the world’s first cell-based milk company using technology to create real milk from animal cells, with no animal needed. The pre-seed round is led by Lever VC, a US-Hong Kong venture capital fund specializing in alternative protein investments, and includes KBW Ventures and Silicon Valley-based K2 Global.

SINGAPORE, Jan. 20, 2020 /PRNewswire/ — TurtleTree Labs, the Singapore-based company working with biotechnology to create the full nutritional content of milk, today announced today that it has completed its pre-seed funding round. Co-founded by CEO Fengru Lin, CSO Rabail Toor, and Chief Strategist Max Rye, TurtleTree Labs is the world’s first cell-based milk company using technology to create real milk

“The Covid-19 situation highlights the need for food security, not just in Singapore, but globally. It is heart-wrenching to see excess milk being dumped because of the global lockdown,” said TurtleTree Labs CEO Fengru Lin.